Literature DB >> 10232742

Elevated ambulatory blood pressure in 20 subjects with Williams syndrome.

K Broder1, E Reinhardt, J Ahern, R Lifton, W Tamborlane, B Pober.   

Abstract

Previous studies report conflicting frequencies of hypertension in cohorts of patients with Williams syndrome (WS). We studied blood pressure (BP) in WS using 24-hour ambulatory BP monitoring. This technique reliably measures day- and nighttime BP in a subject's natural environment and provides better prognostic information on long-term risks of hypertension than casual BP determinations. Twenty WS subjects evaluated through a multidisciplinary WS clinic and 35 age and gender-matched controls were studied. We found that WS subjects had significantly higher ambulatory BP than controls. After controlling for age, sex, and weight, the diagnosis of WS added approximately 10 mmHg to mean daytime and nighttime BPs. Hypertension, as defined by elevated mean daytime BP, was present in 40% of WS subjects versus 14% of controls (P < 0.05); among the children studied this difference was even more dramatic with 46% of WS children versus 6% of control children classified as hypertensive (P = 0.01). We also demonstrated normal diurnal BP variation but no evidence of a "white coat" effect or increased BP variability. Interestingly, parental reporting of a history of infantile hypercalcemia was strongly associated with the presence of hypertension (P = 0.008). Our data demonstrate that both children and adults with WS have higher mean BP and higher frequency of hypertension than healthy controls. Thus, elevated BP readings in the office setting should not be dismissed but require more thorough assessment.

Entities:  

Mesh:

Year:  1999        PMID: 10232742     DOI: 10.1002/(sici)1096-8628(19990423)83:5<356::aid-ajmg2>3.0.co;2-x

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  15 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

Review 2.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

3.  Williams syndrome predisposes to vascular stiffness modified by antihypertensive use and copy number changes in NCF1.

Authors:  Beth A Kozel; Joshua R Danback; Jessica L Waxler; Russell H Knutsen; Lisa de Las Fuentes; Gyorgy S Reusz; Eva Kis; Ami B Bhatt; Barbara R Pober
Journal:  Hypertension       Date:  2013-10-14       Impact factor: 10.190

Review 4.  Copy number variants at Williams-Beuren syndrome 7q11.23 region.

Authors:  Giuseppe Merla; Nicola Brunetti-Pierri; Lucia Micale; Carmela Fusco
Journal:  Hum Genet       Date:  2010-05-01       Impact factor: 4.132

5.  Genetic modifiers of cardiovascular phenotype caused by elastin haploinsufficiency act by extrinsic noncomplementation.

Authors:  Beth A Kozel; Russell H Knutsen; Li Ye; Christopher H Ciliberto; Thomas J Broekelmann; Robert P Mecham
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

Review 6.  Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS).

Authors:  Ramya Sivasubramanian; Kevin E Meyers
Journal:  Curr Hypertens Rep       Date:  2021-03-29       Impact factor: 5.369

7.  Cardiovascular manifestations in 75 patients with Williams syndrome.

Authors:  M Eronen; M Peippo; A Hiippala; M Raatikka; M Arvio; R Johansson; M Kähkönen
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

8.  Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency.

Authors:  Gilles Faury; Mylène Pezet; Russell H Knutsen; Walter A Boyle; Scott P Heximer; Sean E McLean; Robert K Minkes; Kendall J Blumer; Attila Kovacs; Daniel P Kelly; Dean Y Li; Barry Starcher; Robert P Mecham
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 9.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome.

Authors:  Barbara R Pober; Mark Johnson; Zsolt Urban
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

10.  Chronic antihypertensive treatment improves pulse pressure but not large artery mechanics in a mouse model of congenital vascular stiffness.

Authors:  Carmen M Halabi; Thomas J Broekelmann; Russell H Knutsen; Li Ye; Robert P Mecham; Beth A Kozel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.